Oral manifestations, risk factors and management strategies of COVID-19 associated mucormycosis in tertiary care hospital
Description
CONCLUSIONS: Mucormycosis can cause serious oro-facial morbidity and mortality in COVID-19 patients. The current management strategy requires early diagnosis, prompt treatment and oral rehabilitation.
